Similar articles

• Sickle cell disease.

  McCavit TL. McCavit TL. Pediatr Rev. 2012 May;33(5):195-204; quiz 205-6. doi: 10.1542/pir.33-5-195. Pediatr Rev. 2012. PMID: 22550263 Review. No abstract available.
• Sickle cell disease.

  Fixler J, Styles L. Fixler J, et al. Pediatr Clin North Am. 2002 Dec;49(6):1193-210, vi. doi: 10.1016/s0031-3955(02)00089-5. Pediatr Clin North Am. 2002. PMID: 12580362 Review.
• Response to hydroxyurea among Kuwaiti patients with sickle cell disease and elevated baseline HbF levels.

  Adekile A, Menzel S, Gupta R, Al-Sharida S, Farag A, Haider M, Akbulut N, Mustafa N, Thein SL. Adekile A, et al. Am J Hematol. 2015 Jul;90(7):E138-9. doi: 10.1002/ajh.24027. Am J Hematol. 2015. PMID: 25851995 No abstract available.
• Treatment Options for Sickle Cell Disease.

  Meier ER. Meier ER. Pediatr Clin North Am. 2018 Jun;65(3):427-443. doi: 10.1016/j.pcl.2018.01.005. Pediatr Clin North Am. 2018. PMID: 29803275 Review.
• Sickle Cell Disease: Monitoring, Current Treatment, and Therapeutics Under Development.

  Hoppe C, Neumayr L. Hoppe C, et al. Hematol Oncol Clin North Am. 2019 Jun;33(3):355-371. doi: 10.1016/j.hoc.2019.01.014. Epub 2019 Mar 28. Hematol Oncol Clin North Am. 2019. PMID: 31030807 Review.